JNK signaling in cancer cell survival

Q Wu, W Wu, B Fu, L Shi, X Wang… - Medicinal research …, 2019 - Wiley Online Library
Abstract c‐Jun N‐terminal kinase (JNK) is involved in cancer cell apoptosis; however,
emerging evidence indicates that this Janus signaling promotes cancer cell survival. JNK …

Selective inhibitors for JNK signalling: a potential targeted therapy in cancer

Q Wu, W Wu, V Jacevic, TCC Franca… - Journal of enzyme …, 2020 - Taylor & Francis
Abstract c-Jun N-terminal kinase (JNK) signalling regulates both cancer cell apoptosis and
survival. Emerging evidence show that JNK promoted tumour progression is involved in …

[HTML][HTML] The role of autophagy in resistance to targeted therapies

L Mele, V Del Vecchio, D Liccardo, C Prisco… - Cancer Treatment …, 2020 - Elsevier
Autophagy is a self-degradative cellular process, involved in stress response such as
starvation, hypoxia, and oxidative stress. This mechanism balances macro-molecule …

Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways

M Granato, C Rizzello, MSG Montani, L Cuomo… - The Journal of nutritional …, 2017 - Elsevier
Quercetin, a bioflavonoid contained in several vegetables daily consumed, has been
studied for long time for its antiinflammatory and anticancer properties. Quercetin interacts …

[HTML][HTML] Progress on the application of bortezomib and bortezomib-based nanoformulations

J Liu, R Zhao, X Jiang, Z Li, B Zhang - Biomolecules, 2021 - mdpi.com
Bortezomib (BTZ) is the first proteasome inhibitor approved by the Food and Drug
Administration. It can bind to the amino acid residues of the 26S proteasome, thereby …

Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation

C Kao, A Chao, CL Tsai, WC Chuang, WP Huang… - Cell death & …, 2014 - nature.com
The antitumor activity of an inhibitor of 26S proteasome bortezomib (Velcade) has been
observed in various malignancies, including colon cancer, prostate cancer, breast cancer …

ATF6 supports lysosomal function in tumor cells to enable ER stress-activated macroautophagy and CMA: Impact on mutant TP53 expression

R Benedetti, MA Romeo, A Arena… - Autophagy, 2024 - Taylor & Francis
The inhibition of the unfolded protein response (UPR), which usually protects cancer cells
from stress, may be exploited to potentiate the cytotoxic effect of drugs inducing ER stress …

Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: Clue for novel anticancer therapies

G D'Orazi, M Cordani, M Cirone - Cellular and Molecular Life Sciences, 2021 - Springer
Inflammation and cancerogenesis are strongly interconnected processes, not only because
inflammation promotes DNA instability, but also because both processes are driven by …

Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells

MS Gilardini Montani, M Granato, C Santoni… - Cellular Oncology, 2017 - Springer
Abstract Purpose Histone deacetylase inhibitors (HDACi) are anti-neoplastic agents that are
known to affect the growth of different cancer types, but their underlying mechanisms are still …

JNK signaling as a target for anticancer therapy

KS Abdelrahman, HA Hassan, SA Abdel-Aziz… - Pharmacological …, 2021 - Springer
The JNKs are members of mitogen-activated protein kinases (MAPK) which regulate many
physiological processes including inflammatory responses, macrophages, cell proliferation …